- Home
- GDTC vs AIXI Comparison
GDTC vs AIXI Comparison
Compare GDTC & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- AIXI
- Stock Information
- Founded
- GDTC 2018
- AIXI 2001
- Country
- GDTC Singapore
- AIXI China
- Employees
- GDTC N/A
- AIXI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- GDTC Health Care
- AIXI Technology
- Exchange
- GDTC Nasdaq
- AIXI Nasdaq
- Market Cap
- GDTC 28.0M
- AIXI 31.2M
- IPO Year
- GDTC 2023
- AIXI 2023
- Fundamental
- Price
- GDTC $2.21
- AIXI $2.31
- Analyst Decision
- GDTC Buy
- AIXI
- Analyst Count
- GDTC 1
- AIXI 0
- Target Price
- GDTC $5.00
- AIXI N/A
- AVG Volume (30 Days)
- GDTC 6.6K
- AIXI 138.1K
- Earning Date
- GDTC 01-01-0001
- AIXI 05-15-2025
- Dividend Yield
- GDTC N/A
- AIXI N/A
- EPS Growth
- GDTC N/A
- AIXI N/A
- EPS
- GDTC N/A
- AIXI N/A
- Revenue
- GDTC $368,838.00
- AIXI $70,314,315.00
- Revenue This Year
- GDTC $5.37
- AIXI $26.84
- Revenue Next Year
- GDTC N/A
- AIXI N/A
- P/E Ratio
- GDTC N/A
- AIXI N/A
- Revenue Growth
- GDTC N/A
- AIXI 18.84
- 52 Week Low
- GDTC $1.20
- AIXI $2.06
- 52 Week High
- GDTC $4.05
- AIXI $8.31
- Technical
- Relative Strength Index (RSI)
- GDTC 49.36
- AIXI 41.81
- Support Level
- GDTC $2.09
- AIXI $2.20
- Resistance Level
- GDTC $2.35
- AIXI $2.60
- Average True Range (ATR)
- GDTC 0.10
- AIXI 0.31
- MACD
- GDTC 0.00
- AIXI -0.01
- Stochastic Oscillator
- GDTC 50.00
- AIXI 23.33
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.